NCT03962543 2026-04-08ReNeuSpringWorks Therapeutics, Inc.Phase 2 Active not recruiting114 enrolled 25 charts 3 FDA
NCT03820778 2021-03-02Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1Children's National Research InstitutePhase NA Active not recruiting10 enrolled